Prescribing pathways to triple therapy in patients with chronic obstructive pulmonary disease in the United States.
Vernon SchabertSurbhi ShahUlf HolmgrenClaudia CabreraPublished in: Therapeutic advances in respiratory disease (2021)
The study has revealed discrepancies in the treatment of COPD patients between GOLD guidelines and actual clinical practices in the United States. Pathways to TT differed from recommended therapy regimes. Further studies are needed to understand barriers to the use of guideline-recommended TTs by healthcare providers.The reviews of this paper are available via the supplemental material section.
Keyphrases
- healthcare
- primary care
- end stage renal disease
- newly diagnosed
- chronic obstructive pulmonary disease
- ejection fraction
- prognostic factors
- peritoneal dialysis
- emergency department
- systematic review
- stem cells
- lung function
- single cell
- cystic fibrosis
- mesenchymal stem cells
- replacement therapy
- smoking cessation
- electronic health record
- patient reported
- case control